Progenics Pharmaceuticals Announces FDA Acceptance of New Drug Application for Azedra (iobenguane I 131) in Pheochromocytoma and Paraganglioma
NEW YORK, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, announced today that the U.S. Food and... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - December 29, 2017 Category: Drugs & Pharmacology Source Type: news
Progenics Pharmaceuticals Completes Submission of NDA for Azedra (iobenguane I 131) in Pheochromocytoma and Paraganglioma
NEW YORK, Nov. 02, 2017 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, announced today that it has completed the... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - November 2, 2017 Category: Drugs & Pharmacology Source Type: news
Pheochromocytoma and Paraganglioma in Children
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - October 26, 2017 Category: General Medicine Source Type: news
Medical News Today: Pheochromocytoma: Symptoms, diagnosis, and treatment
What is pheochromocytoma and what is the adrenal gland? In this article, learn about the causes of pheochromocytoma and its potential complications. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 3, 2017 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news
Preoperative Management for Phaeochromocytoma/Paraganglioma Preoperative Management for Phaeochromocytoma/Paraganglioma
Find out what the available evidence tells us about the preoperative management of patients with phaeochromocytomas and paragangliomas.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 22, 2017 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
New study links'mastermind' gene to rare cancer-causing tumor
Scientists have discovered a new " mastermind fusion gene " may be associated with a rare cancer-causing tumor -- pheochromocytomas ( " pheo " ) and paragangliomas -- according to a study. This breakthrough discovery could lead to more precise treatment as well as a better understanding of cancer itself. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 13, 2017 Category: Science Source Type: news
In-depth gene search reveals new mutations, drug targets in rare adrenal tumors
(University of Pennsylvania School of Medicine) Casting one of the largest genomic nets to date for the rare tumors of the autonomic nervous system known as pheochromocytoma and paraganglioma (PCC/PGL) captured several new mutations driving the disease that could serve as potential drug targets, researchers from Penn Medicine and other institutions reported this week in Cancer Cell. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 13, 2017 Category: Global & Universal Source Type: news
Pheochromocytoma
Title: PheochromocytomaCategory: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 9/6/2016 12:00:00 AM (Source: MedicineNet High Blood Pressure General)
Source: MedicineNet High Blood Pressure General - September 6, 2016 Category: Cardiology Source Type: news
Study identifies important predictors for PC/PGL
BALTIMORE – Tumor size and the presence of mutations of the succinate dehydrogenase complex subunit B (SDHB) gene may be reliable indicators of prognosis after surgery for pheochromocytoma and... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - July 13, 2016 Category: Endocrinology Source Type: news
Perioperative Care of PhaeochromocytomaPerioperative Care of Phaeochromocytoma
This article reviews the essentials of perioperative care and monitoring in patients with pheochromocytomas and paragangliomas. BJA Education (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 7, 2016 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news
Adrenoceptor Blockade for Hormonally Functional Pheo/PGLAdrenoceptor Blockade for Hormonally Functional Pheo/PGL
A new study examines whether patients with hormonally functional pheochromocytomas and paragangliomas (pheo/PGLs) are receiving the appropriate pharmacological treatment. Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 5, 2016 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
Adrenal gland tumors linked to ADHD diagnosis
Published in Hormone and Metabolic Research, a study found that paediatric patients with pheochromocytomas (PHEO) or paragangliomas (PGL) were nearly three times more likely to also carry a diagnosis of ADHD.
Clinical Endocrinology News (Source: Society for Endocrinology)
Source: Society for Endocrinology - May 20, 2016 Category: Endocrinology Source Type: news
Adrenal gland tumors linked to ADHD diagnosis
Pediatric patients diagnosed with pheochromocytomas (PHEO) or paragangliomas (PGL) were nearly three times as likely to also carry a diagnosis of attention deficit hyperactivity disorder (ADHD),... (Source: Pediatric News)
Source: Pediatric News - May 19, 2016 Category: Journals (General) Source Type: news
Adrenal gland tumors linked to ADHD diagnosis
Pediatric patients diagnosed with pheochromocytomas (PHEO) or paragangliomas (PGL) were nearly three times as likely to also carry a diagnosis of attention deficit hyperactivity disorder (ADHD),... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - May 19, 2016 Category: Endocrinology Source Type: news
Quantification of Metanephrine and Normetanephrine in Urine Using Liquid Chromatography-Tandem Mass Spectrometry
Measuring urinary metanephrines aides in the diagnosis of pheochromocytomas–catecholamine producing tumors. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) allows for greater sensitivity and simpler sample preparation as compared with other techniques. Here we describe a simple LC-MS/MS method for measuring metanephrines in urine. Each urine sample was treated with diphenylboronic acid to create boronate complexes, and then applied to a Bond-Elut Plexa cartridge. After solid phase extraction, samples were concentrated and analyzed on an Atlantis T3 column with chromatographic run time totaling 8.5 min. MS/M...
Source: Springer protocols feed by Imaging/Radiology - November 27, 2015 Category: Radiology Source Type: news
